Excessive inflammatory cell infiltration or diffuse lamellar keratitis (DLK) is probably attributable to endogenous factors that trigger inflammation, mainly secondary to epithelial injury after LASIK.
26 Although the etiology of DLK is unknown, several reports have linked epithelial defects, trauma, Meibomian gland secretions, and bacterial toxins with DLK.
27 The genesis of DLK can be associated with the release of proinflammatory cytokines from the corneal epithelium and flap interface. A platelet-activating-factor receptor antagonist was reported to block both the induction of DLK and keratocyte apoptosis.
28 The severity of gutter in the corneal flap margin was also associated with the incidence of DLK.
29 As mentioned earlier, Solomon et al.
19 used SEM to show that surface irregularity was greater in the beds of lamellar keratectomies created with an FS laser than those created with an MM. Because the flap edge created with an FS laser can be deeply cut or irregular, re-epithelialization may take more time, and more inflammatory cells may infiltrate in the flap interface than with an MM. In contrast, Binder
20 described 20 cases of interface inflammation (DLK) in which there was no effect on visual outcome after LASIK with an FS laser.
20 Decreases in the side-cut energy and side-cut angle eliminated the interface inflammation. In that series, a side-cut energy of 6 to 8 μJ, which was considerably higher than the 3.2 μJ used in our study, was applied. Although it was difficult to compare the data from both studies directly, because different experimental subjects were involved, the side-cut energy could be related to inflammatory cell infiltration in the FS group. Furthermore, the higher energy of an FS laser than that of an MM could explain the more inflammatory cell infiltration in the corneal stoma in the FS group in this study. Using a lower side-cut energy can alleviate such inflammatory cell infiltration.
20 In particular, we found prominent inflammatory cell infiltration after FS laser LASIK using this animal model. Thus, after a flap is created with an FS laser, stronger anti-inflammatory drugs may to be necessary to control postoperative inflammation.